Display options
Share it on

Public Health Action. 2014 Sep 21;4(3):159-63. doi: 10.5588/pha.14.0023.

Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji.

Public health action

P Prasad, S Gounder, S Varman, K Viney

Affiliations

  1. College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.
  2. National Tuberculosis Programme, Fiji Ministry of Health, Suva, Fiji.
  3. Public Health Division, Secretariat of the Pacific Community, Nouméa, New Caledonia ; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.

PMID: 26400803 PMCID: PMC4533811 DOI: 10.5588/pha.14.0023

Abstract

SETTINGS: Three tuberculosis (TB) treatment centres under the Fiji National Tuberculosis Programme.

OBJECTIVES: To determine the prevalence of diabetes mellitus (DM) among TB patients for the period 2010-2012, and to evaluate sputum smear conversion and anti-tuberculosis treatment outcomes, comparing patients with and without DM.

DESIGN: A retrospective descriptive study using routinely collected data from the TB register and in-patient folders.

RESULTS: Of 577 TB patients identified, information on DM was available for 567 (98%), of whom 68 (12%) had DM. Smear status at 2 months was available for 254 (82%) patients with sputum smear-positive pulmonary TB. The sputum smear conversion rate (from positive to negative) was equivalent in TB patients with and without DM (78% vs. 80%, P = 0.66). Anti-tuberculosis treatment outcome information was available for 462 patients; the difference in outcome comparing successfully treated patients with those unsuccessfully treated was not statistically significant (91% in TB patients with DM vs. 84% in TB patients without DM, P = 0.06).

CONCLUSION: DM is common among TB patients in Fiji. Sputum smear conversion rates were not different in TB patients with and without DM; no difference in treatment success between the two groups was observed.

Keywords: Fiji; diabetes mellitus; treatment outcomes; tuberculosis

References

  1. PLoS Med. 2008 Jul 15;5(7):e152 - PubMed
  2. Public Health Action. 2013 Nov 4;3(Suppl 1):S48-50 - PubMed
  3. Public Health Action. 2012 Dec 21;2(4):145-7 - PubMed
  4. PLoS One. 2012;7(7):e41367 - PubMed
  5. Int J Tuberc Lung Dis. 2001 May;5(5):455-61 - PubMed
  6. Int J Tuberc Lung Dis. 2011 Mar;15(3):337-43 - PubMed
  7. Chronic Illn. 2007 Sep;3(3):228-45 - PubMed
  8. PLoS One. 2011;6(8):e24215 - PubMed
  9. BMC Med. 2011 Jul 01;9:81 - PubMed
  10. Epidemiol Infect. 2009 Feb;137(2):203-10 - PubMed
  11. Am J Trop Med Hyg. 2009 Apr;80(4):634-9 - PubMed
  12. Int J Infect Dis. 2011 Dec;15(12):e818-21 - PubMed
  13. Int J Tuberc Lung Dis. 2006 Jun;10(6):696-700 - PubMed
  14. Thorax. 2013 Mar;68(3):214-20 - PubMed
  15. Public Health Action. 2013 Nov 4;3(Suppl 1):S38-42 - PubMed
  16. Bull World Health Organ. 2005 Jul;83(7):503-10 - PubMed
  17. J Formos Med Assoc. 2011 Jun;110(6):372-81 - PubMed
  18. Diabetes Res Clin Pract. 2012 Jun;96(3):385-91 - PubMed
  19. Clin Infect Dis. 2007 Aug 15;45(4):428-35 - PubMed
  20. Saudi Med J. 2003 Mar;24(3):278-81 - PubMed

Publication Types